Literature DB >> 412208

Deficits in passive-avoidance learning following atropine in the developing rat.

D Blozovski, A Cudennec, D Garrigou.   

Abstract

The maturation of cholinergic inhibitory mechanisms that may be involved in passive-avoidance learning was studied in rats 14, 17, 21, 25, 28, and 34 days of age. Acquisition and extinction of the conditioned response were examined under saline and atropine sulfate (5 mg/kg). Learning was also tested following scopolamine hydrobromide injections (1, 4, 8 mg/kg) in rats 17 days of age and following alpha-methylatropine (5 mg/kg) in 17- and 34-day-old groups. In normal animals the rate of acquisition increased during ontogenesis, with a significant improvement between postnatal days 17 and 21, whereas the rate of extinction did not vary with age. Acquisition was impaired by atropine sulfate at all ages and even totally prevented in younger groups (14 and 17 days of age). It was also completely disrupted by scopolamine in 17-day-old rats. Extinction following acquisition under atropine was more rapid than after normal acquisition. Methyl-atropine was without effect. These results support the hypothesis of central cholinergic mechanisms involved in response suppression, already functioning in the rat 14 days of age and maturing mainly between the 17th and the 21st postnatal days.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412208     DOI: 10.1007/bf00426769

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Effects of scopolamine on activity and passive avoidance learning in rats of different ages.

Authors:  D A Feigley
Journal:  J Comp Physiol Psychol       Date:  1974-07

2.  Escape learning: acquisition and extinction rates as a function of age in rats.

Authors:  G J Egger
Journal:  Dev Psychobiol       Date:  1974-05       Impact factor: 3.038

3.  The ontogeny of a hippocampus-dependent response in two rodent species.

Authors:  R J Douglas; J J Peterson; D P Douglas
Journal:  Behav Biol       Date:  1973-01

4.  Age effects in the acquisition and retention of active and passive avoidance learning by rats.

Authors:  G J Egger; P J Livesey
Journal:  Dev Psychobiol       Date:  1972       Impact factor: 3.038

5.  Age-related deficits in acquisition of a passive aviodance response.

Authors:  D C Riccio; C J Schulenburg
Journal:  Can J Psychol       Date:  1969-12

6.  Cholinergic modulation of adrenergic arousal in the developing rat.

Authors:  H C Fibiger; L D Lytle; B A Campbell
Journal:  J Comp Physiol Psychol       Date:  1970-09

7.  Some effects of scopolamine on a passive avoidance response in rats.

Authors:  B Meyers
Journal:  Psychopharmacologia       Date:  1965-07-28

8.  Ontogeny of starvation-induced behavioral arousal in the rat.

Authors:  W H Moorcroft; L D Lytle; B A Campbell
Journal:  J Comp Physiol Psychol       Date:  1971-04

9.  Impairment of one-trial passive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine.

Authors:  Z Bohdanecký; M E Jarvik
Journal:  Int J Neuropharmacol       Date:  1967-05

10.  Effect of atropine on behavioral arousal in the developing rat.

Authors:  D Blozovski; J Bachevalier
Journal:  Dev Psychobiol       Date:  1975-03       Impact factor: 3.038

View more
  4 in total

1.  Effects of antimuscarinic cholinergic drugs injected systemically or into the hippocampo-entorhinal area upon passive avoidance learning in young rats.

Authors:  D Blozovski; N Hennocq
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

2.  Development of amygdaloid cholinergic mediation of passive avoidance learning in the rat. II. Nicotinic mechanisms.

Authors:  D Blozovski; V Duméry
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

3.  Deficits in passive avoidance learning in young rats following mecamylamine injections in the hippocampo-entorhinal area.

Authors:  D Blozovski
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

Review 4.  Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists.

Authors:  Joseph I Friedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.